Abstract:In classic ‘ball-and-stick’ models of haematopoiesis the implicit assumption is that all cells within each defined stem or progenitor cell population are equivalent in their fate. Instead, more recent models suggest a haematopoietic stem and progenitor cell (HSPC) ‘continuum’ of lineage bias and commitment, which is largely inferred through ‘snapshot’ analysis of single cell gene expression or clonal fate. However, the dynamic assessment of lineage commitment of specific HSPC populations and their clonal output over time is still lacking but is essential to fully inform accurate models of haematopoiesis. Here, using cellular barcoding we compare the single cell output of long-term haematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), multipotent progenitors (LMPPs), common myeloid progenitors (CMPs), common lymphoid progenitors (CLPs), and macrophage/dendritic cell progenitors (MDPs). Each population was assessed for their output to multiple haematopoietic cell types spanning a subset of time points from 9 to 112 days of haematopoiesis after transplantation. These analyses revealed a wide range of clonal fate patterns that were inconsistent with their eponymous labels, i.e. stem and multipotent progenitors were rarely multi- or equipotent, and ‘common’ progenitors were often highly restricted in their fate. To better describe how these clonal patterns integrate into a revised landscape, a novel agent-based mathematical modelling approach that explicitly accounts for haematopoiesis at a clonal level was developed to allow the simulation of growth, timing and branching of clonal trajectories that underlie the process. Rather than a continuum, the proposed model is suggestive of multiple tracks down which clonal trajectories progress, and where fate can branch to a track of lower potency at multiple points down the entire cascade of haematopoiesis.

Non-hierarchically related HSCs replenish platelets by distinct progenitor pathways

From Hematopoietic Stem Cells to Platelets: Unifying Differentiation Pathways Identified by Lineage Tracing Mouse Models

A Single-Cell Hematopoietic Landscape Resolves 8 Lineage Trajectories and Defects in Kit Mutant Mice.

Alternative platelet differentiation pathways initiated by nonhierarchically related hematopoietic stem cells

Stable platelet production via the bypass pathway explains the long-term reconstitution capacity of hematopoietic stem cells

Revisiting the lineage contribution of hematopoietic stem and progenitor cells

A landscape of haematopoiesis informed by cellular barcoding and agent-based modelling

Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

Hematopoietic Stem Cell Fates and the Cellular Hierarchy of Mammalian Hematopoiesis: from Transplantation Models to New Insights from in Situ Analyses

Clonal analysis of murine HSC self-renewal and differentiation in native hematopoiesis

3061 – SERIAL TRANSPLANTABLE HEMATOPOIETIC STEM CELLS IDENTIFIED BY SINGLE-CELL CLONAL TRACKING

Hematopoietic stem cell heterogeneity and age-associated platelet bias are evolutionarily conserved

Redefining hematopoietic progenitor cells and reforming the hierarchy of hematopoiesis

Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations

Human haematopoietic stem cell lineage commitment is a continuous process

Stochastic fate decisions of HSCs after transplantation: early contribution, symmetric expansion, and pool formation

Clonal and Quantitative In Vivo Assessment of Hematopoietic Stem Cell Differentiation Reveals Strong Erythroid Potential of Multipotent Cells

3052 – EXTENSIVE ANALYSIS OF HEMATOPOIETIC STEM CELLS AFTER SINGLE-CELL TRANSPLANTATION

Clonal Tracking of the Source of Red Cell and Platelet Production in Rhesus Macaques

Tracing the Formation of Haematopoietic Stem Cells in Mouse Embryos by Single-Cell Functional and RNA-Seq Analyses

Hematopoietic stem cell heterogeneity and age-related platelet bias: implications for bone marrow transplantation and blood disorders